This Friday (17th), the first day of the Hemostasis and Thrombosis Educational Course took place in Belo Horizonte (MG), with 160 enrolled. At the opening of the meeting, the coordinator of the ABHH Hemostasis and Thrombosis Committee, Dr. Ana Clara Kneese, announced that the purpose of the course is to be practical, “not necessarily about coagulation, but about important factors so that everyone has the necessary knowledge in emergency cases or referred, in a practical way”.
Soon after, the Managing Director of ABHH, hematologist Dr. Glaciano Ribeiro from Minas Gerais, welcomed those present and presented the benefits of being associated with ABHH, including the new access to the Clinical Key library. In the first thematic session, Dr. Suely Rezende, also a member of the ABHH Committee, spoke about Antiphospholipid Antibody Syndrome (SAA). According to her, there is still little evidence to guide treatment, but in recent years, some studies have demonstrated advances with intermediate outcomes.
In a critical discussion about the new thrombophilia guideline from the American Society of Hematology (ASH), Suely paid tribute to Frida Kahlo, revealing that the activist who had an amputated leg probably suffered from a thrombophilic disease, according to academic reports. Marcelo Luide Pereira Gonçalves also participated in this table.
During the presentations, Professor Dayse Lourenço, also from the ABHH Committee that organized the event, brought up a topic under wide debate, which is the conduct of hormonization in trans people and the monitoring of the risks of thrombosis and other coagulation problems. Check out a video she recorded after her performance.
The respected Director of the Hematology Division of the Medical Clinic Department of Unicamp, Margareth Ozelo, began the session on hemophilia, stressing that advances in treatments have increased the expectancy and quality of life of people with the disease, but also raised practical questions. “How to deal with a patient at risk of a heart attack and who treats bleeding disorders, such as hemophilia? Cases of thrombophilic diseases are also challenging,” he said.
The afternoon program started again with Dr. Ana Clara Kneese, who opened the presentations on Plaquetopenia. “Patients with risk factors should be evaluated in relation to prophylactic or hemostatic treatments,” he provoked when clarifying the issue during his presentation.
Next, regarding the challenges of treating Idiopathic Thrombocytopenic Purpura (ITP), a disease considered rare, Dr. Raquel Delgado focused her presentation on case analyses in the elderly. “The more we know the patient, the more treatment possibilities we have,” he encouraged. At the same table, Dr. João Carlos de Campos Guerra recalled that “mortality from Thrombocytopenic Purpura is 95% when not diagnosed and treated early”.
In another debate, Dr. Ana Clara Kneese emphasized that “integration with the patient's experience, observations, and family monitoring are fundamental to treatment decisions”.
At the opening of the last session of the day, Dr. Fernanda Orsi highlighted the topic of women's health at the event. “We need to understand that women's health is not limited to the reproductive system, but concerns the entire body,” she said, handing the microphone to Dr. Erich de Paula, from Unicamp, who gave a detailed presentation on the diagnosis and choice of treatments in women who use contraceptives versus blood disorders.
The ABHH Hemostasis and Thrombosis Course program continues this Saturday morning (18). The classes will be available later at the Hemoteca.
Check out some photographic records of the event on our social networks (@abhhoficial)
